By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

Apeiron Biologics gets a EUR 25 million loan from EIB

Apeiron CEO H. Loibner © Apeiron Biologics

The funds are designed to help the company develop new pharmaceutical products for the treatment of cancer, especially rare types affecting children. The financing for Apeiron was made possible by the “European Fund for Strategic Investments” (EFSI).

Apeiron was founded in 2003 by the geneticist Josef Penninger, the scientific director of the Institute for Molecular Biology (IMBA) in Vienna. In May 2017, the European Commission granted market approval for a therapy focusing on immunotherapy of neuroblastoma. The therapy should increase the survival and chances of recovery for the serious cancer neuroblastoma which affects children at an early age. It is a rare cancer, but is responsible for up to 10% of solid tumors in childhood, affecting about 1,200 children in the EU and USA every year.  

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

Austria Map

Find the perfect location for your company

The "mental closeness" of Austria to its neighbours is an important advantage for establishing new business contacts.

Ericsson Austria

Logo
More testimonials

news from the business location Austria

Space telescope CHEOPS delivers initial results

The space exploration mission CHEOPS has been providing initial exciting results from outer space.

Welcome to the future of legal transactions

Thanks to an initiative of the Austrian Chamber of Civil-Law Notaries, Austria is playing a pioneering role in connection with the digital foundation of companies.

More news All blog posts